These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 618598)

  • 21. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats.
    Jover B; Dupont M; Mimran A; Woods R; McGrath B
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H763-9. PubMed ID: 2889370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of vasopressin in blood pressure control of spontaneously hypertensive rats.
    Möhring J; Kintz J; Schoun J
    Clin Sci Mol Med Suppl; 1978 Dec; 4():246s-250s. PubMed ID: 282062
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of two-kidney Goldblatt hypertension in rats under dietary sodium restriction.
    Muñoz-Ramírez H; Chatelain RE; Bumpus FM; Khairallah PA
    Am J Physiol; 1980 Jun; 238(6):H889-94. PubMed ID: 6992601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.
    Laragh JH; Sealey JE; Bühler FR; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Med; 1975 Jan; 58(1):4-13. PubMed ID: 234677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of vasopressin in experimental and clinical hypertension.
    Krakoff LR; Elijovich F; Barry C
    Am J Kidney Dis; 1985 Apr; 5(4):A40-7. PubMed ID: 3887902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the pathogenesis of the malignant course of renal hypertension in rats.
    Möhring J; Möhring B; Petri M; Haack D; Hackenthal E
    Kidney Int Suppl; 1975 Sep; ():S174-80. PubMed ID: 1059802
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure.
    Gavras H; Hatzinikolaou P; North WG; Bresnahan M; Gavras I
    Hypertension; 1982; 4(3):400-5. PubMed ID: 7040232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of vasopressin in hypertension: studies using the Brattleboro rat.
    Woods RL; Johnston CI
    Am J Physiol; 1982 Jun; 242(6):F727-32. PubMed ID: 7091324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salt loss as a possible mechanism eliciting an acute malignant phase in renal hypertensive rats.
    Gross F; Dietz R; Mast GJ; Szokol M
    Clin Exp Pharmacol Physiol; 1975; 2(4):323-33. PubMed ID: 1149333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB; Davies DL; Leckie B; Morton JJ; Brown JJ; Fraser R; Lever AF; Robertson JI
    Lancet; 1979 Sep; 2(8143):606-9. PubMed ID: 90271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vasopressin in blood pressure control and in experimental hypertension.
    Pullan PT; Johnston CI; Anderson WP; Korner PI
    Clin Sci Mol Med Suppl; 1978 Dec; 4():251s-254s. PubMed ID: 282063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular and renal responses to chronic vasopressin infusion.
    Brown AJ; Lohmeier TE; Carroll RG; Meydrech EF
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H584-94. PubMed ID: 3515969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of renal hypertension: effects on renin, salt and water balance.
    Dietz R; Mast GJ; Schömig A; Lüth JB; Rascher W
    Klin Wochenschr; 1978; 56 Suppl 1():23-9. PubMed ID: 732250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salt and water balance and renin activity in renal hypertension of rats.
    Möhring J; Möhring B; Näumann H-J ; Philippi A; Homsy E; Orth H; Dauda G; Kazda S
    Am J Physiol; 1975 Jun; 228(6):1847-55. PubMed ID: 1155615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    Clin Exp Pharmacol Physiol; 1982; 9(3):297-301. PubMed ID: 6754178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic intravenous administration of V1 arginine vasopressin agonist results in sustained hypertension.
    Cowley AW; Szczepanska-Sadowska E; Stepniakowski K; Mattson D
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H751-6. PubMed ID: 8067431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
    Laragh JH
    Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.